Read more
12:55 PM · 13 October 2022

Walgreens surges in premarket on upbeat quarterly results

-
-
Open account Download free app

Walgreens (WBA.US) stock briefly jumped nearly 7.0% in the premarket after the drugstore operator posted better-than-expected quarterly profit and revenue. The company also raised its long-term sales targets.

  • The drugstore chain earned 80 cents per share, down 31.6% from the same period last year, however 3 cents above analysts’ estimates. Revenues dropped 5.3% from last year to $32.4 billion, beating market consensus of a $32.085 billion tally, as U.S. same-store sales rose 1.6%.
  • Comparable sales at Boots, its U.K.-based division, jumped 15.2% from last year, even amid a 6.9% slump in overall pharmacy revenues. 
  • When it comes to fiscal 2023, the company expects adjusted EPS of $4.45 to $4.65, in the midpoint of the FactSet projections of $4.51. U.S. Healthcare fiscal 2025 sales target was lifted to $11 billion to $12 billion from $9 billion to $10 billion. 

Walgreens (WBA.US) stock plunged over 14.0% within the past three months. Stock rose sharply before the opening bel, however most of the gains were erased after US CPI release. Currently price is trading near the upper limit of the local descending channel. However if current sentiment prevails, another downward move may be launched towards recent lows at $30.45. Source: xStation5

21 January 2026, 1:12 PM

Nvidia chart warning?🔎 Head-and-shoulders pattern takes shape

20 January 2026, 9:30 PM

Netflix down 5% after Q4 results 📉 Is Wall Street turning bearish?

20 January 2026, 6:54 PM

Daily Summary: "Sell America" pushes US assets off the cliff (20.01.2026)

20 January 2026, 3:21 PM

Banks fear Trump📉Central planning in the USA?

Join over 2 000 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits